We are live on
!
Find out more
VA
Vident Advisory Portfolio holdings
AUM
$11.7B
1-Year Est. Return
37.32%
This Fund
S&P 500
This Quarter
Est. Return
+1.93%
1 Year Est. Return
+37.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11B
AUM Growth
+$516M
(+4.9%)
Cap. Flow
+$571M
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
1,754
New
123
Increased
661
Reduced
828
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$128M |
| 2 |
Oracle
ORCL
|
+$52M |
| 3 |
Microsoft
MSFT
|
+$42M |
| 4 |
iShares Gold Trust Micro
IAUM
|
+$38.2M |
| 5 |
Broadcom
AVGO
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Textron
TXT
|
+$33.7M |
| 2 |
Strategy Inc
MSTR
|
+$20.7M |
| 3 |
Palantir
PLTR
|
+$20.5M |
| 4 |
L3Harris
LHX
|
+$18.9M |
| 5 |
Northrop Grumman
NOC
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.87% |
| 2 | Industrials | 13.69% |
| 3 | Financials | 11.84% |
| 4 | Communication Services | 7.41% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
F&G Annuities & Life
FG
$3.93B
| $299K | ﹤0.01% |
9,680
-7,029
| -42% | -$220K |
|
|
WRD
1377
WeRide Inc
WRD
$1.75B
| $298K | ﹤0.01% |
+34,277
| New | +$319K |
|
1378
Standex International
SXI
$3.68B
| $297K | ﹤0.01% |
+1,368
| New | +$317K |
|
1379
International Flavors & Fragrances
IFF
$19.4B
| $297K | ﹤0.01% |
4,410
-1,438
| -25% | -$93.1K |
|
1380
Star Bulk Carriers
SBLK
$3.14B
| $297K | ﹤0.01% |
15,463
-1,439
| -9% | -$26.9K |
|
1381
Knife River
KNF
$4.43B
| $297K | ﹤0.01% |
+4,221
| New | +$296K |
|
1382
Sibanye-Stillwater
SBSW
$5.92B
| $296K | ﹤0.01% |
20,789
-208,903
| -91% | -$2.53M |
|
1383
Ferrovial N.V. Ordinary Shares
FER
$45.3B
| $296K | ﹤0.01% |
+4,620
| New | +$292K |
|
1384
Vanguard Ultra-Short Bond ETF
VUSB
$8.93B
| $292K | ﹤0.01% |
+5,867
| New | +$293K |
|
1385
Corebridge Financial
CRBG
$14.1B
| $292K | ﹤0.01% |
9,679
-3,149
| -25% | -$96.8K |
|
1386
Clorox
CLX
$11.6B
| $291K | ﹤0.01% |
2,890
-1,997
| -41% | -$217K |
|
1387
Driven Brands
DRVN
$2.25B
| $291K | ﹤0.01% |
19,620
+1,458
| +8% | +$21.7K |
|
1388
Asana
ASAN
$1.58B
| $290K | ﹤0.01% |
21,135
-1,392
| -6% | -$19.1K |
|
1389
Avery Dennison
AVY
$12.3B
| $289K | ﹤0.01% |
1,589
-273
| -15% | -$47.2K |
|
1390
BioMarin Pharmaceuticals
BMRN
$11.5B
| $289K | ﹤0.01% |
4,859
-3,844
| -44% | -$209K |
|
1391
VinFast Auto
VFS
$6.67B
| $289K | ﹤0.01% |
86,449
+36,198
| +72% | +$121K |
|
1392
Franco-Nevada
FNV
$41.4B
| $288K | ﹤0.01% |
1,391
-10,192
| -88% | -$2.07M |
|
1393
Viking Therapeutics
VKTX
$4.04B
| $287K | ﹤0.01% |
+8,167
| New | +$289K |
|
1394
ODDITY Tech
ODD
$708M
| $287K | ﹤0.01% |
7,144
+2,679
| +60% | +$121K |
|
1395
Pilgrim's Pride
PPC
$6.82B
| $285K | ﹤0.01% |
7,302
-28,077
| -79% | -$1.08M |
|
1396
Vita Coco
COCO
$3.77B
| $284K | ﹤0.01% |
+5,356
| New | +$251K |
|
1397
CNO Financial Group
CNO
$4.97B
| $284K | ﹤0.01% |
6,684
-1,865
| -22% | -$76K |
|
1398
TG Therapeutics
TGTX
$8.58B
| $284K | ﹤0.01% |
9,517
-2,086
| -18% | -$68.1K |
|
|
JBS
1399
JBS N.V.
JBS
$40.4B
| $282K | ﹤0.01% |
19,584
-3,445
| -15% | -$47.3K |
|
1400
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $282K | ﹤0.01% |
3,533
| – | – |
|
Similar funds
HTC
BCI
VIA
NYLIM
PI
UE
LC
MG
Vident Advisory's Q4 2025 Portfolio in Review
As of Q4 2025, Vident Advisory held 1,754 positions worth $11B, up 4.9% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Vident Advisory deployed $571M of net new capital in Q4 2025, opening 123 new positions and adding to 661 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 479,344 shares worth $34.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Textron, an estimated $33.7M trimmed.
- Vident Advisory's largest Q4 2025 buy was iShares MSCI Emerging Markets ex China ETF: 479,344 shares worth $34.8M.
- Vident Advisory added most to Lockheed Martin in Q4 2025, an estimated $128M increase.
- Vident Advisory's biggest Q4 2025 reduction was Textron, cutting an estimated $33.7M.
- Vident Advisory fully exited Schwab International Small-Cap Equity ETF in Q4 2025, selling an estimated $10.8M.
- Vident Advisory's ten largest holdings make up 21% of its $11B portfolio in Q4 2025.
- Vident Advisory opened 123 new positions and closed 128 in Q4 2025.
- Vident Advisory's portfolio value rose 4.9% quarter-over-quarter to $11B.
Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.